Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

71.79 

0.01 0.0%

as of Aug 22 '19

52 Week Range:

48.78 76.47


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. It also provides HealtheIntent platform, a cloud-based platform to aggregate, transform, and reconcile data across the continuum of care; and EHR agnostic platform, CareAware that facilitates connectivity of health care devices to EHRs. In addition, the company offers a portfolio of clinical and financial health care information technology solutions, as well as departmental, connectivity, population health, and care coordination solutions. Further, it provides tech-enabled services, such as implementation and training, remote hosting, operational management services, revenue cycle services, support and maintenance, health care data analysis, clinical process optimization, transaction processing, employer health centers, employee wellness programs, and third-party administrator services; and complementary hardware and devices for third parties. The company serves integrated integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments and public health organizations. It has a strategic collaboration with Christiana Care Health System to provide a weight loss surgery program. Cerner Corporation was founded in 1979 and is headquartered in North Kansas City, Missouri.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Jan '15 Oct '15 Jan '16 Oct '16 Dec '17 Dec '18
Equity (BVPS) 5.75
6.51
8.23
8.95
9.95
11.22
12.98
13.73
15.62
growth rate 13.2% 26.4% 8.8% 11.2% 6.2% 7.6% 5.8% 13.8%
Earnings BIT 469.69
587.71
588.05
779.08
873.14
947.01
960.47
774.79
growth rate 25.1% 0.1% 15.1% 5.9% 8.5% 1.4% -19.3%
Avg.PE 34.72
34.25
49.26
33.42
30.35
30.52
30.64
growth rate -1.4% 43.8% -12.1% -4.7% 0.6% 0.4%
ROA 10.38
11.31
11.85
10.21
12.18
10.69
11.37
14.33
9.56
growth rate 9.0% 4.8% -13.8% 19.3% -6.3% 3.1% 26.0% -33.3%
ROE 13.61
14.55
15.44
13.28
15.61
14.51
16.32
19.90
12.97
growth rate 6.9% 6.1% -14.0% 17.6% -3.6% 6.1% 21.9% -34.8%
ROIC 12.71
13.54
14.25
12.28
14.71
13.20
14.03
17.49
11.41
growth rate 6.5% 5.2% -13.8% 19.8% -5.3% 3.1% 24.7% -34.8%
Cur. Ratio 3.75
3.42
3.09
2.75
3.70
2.35
1.92
3.01
2.41
growth rate -8.8% -9.7% -11.0% 34.6% -20.3% -9.6% 56.8% -19.9%
Quick Ratio 3.43
3.05
2.78
2.28
3.30
1.99
1.54
2.34
2.03
growth rate -11.1% -8.9% -18.0% 44.7% -22.3% -12.0% 52.0% -13.3%
Leverage 1.27
1.30
1.31
1.29
1.27
1.44
1.43
1.35
1.36
growth rate 2.4% 0.8% -1.5% -1.6% 6.5% -0.4% -5.6% 0.7%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Jan '15 Oct '15 Jan '16 Oct '16 Dec '17 Dec '18
Acct.Receivable 0.00
610.00
616.47
674.54
672.78
1,034.08
944.94
1,042.78
1,183.49
growth rate 1.1% 9.4% -0.1% 24.0% -8.6% 10.4% 13.5%
Acct.Payable 245.86
330.88
376.58
160.29
215.51
238.13
219.00
293.53
growth rate 34.6% 13.8% -34.8% 16.0% 10.5% -8.0% 34.0%
Cur.Assets 1,146.10
1,502.31
1,790.51
1,761.71
2,348.79
1,827.83
1,619.36
2,380.23
2,318.80
growth rate 31.1% 19.2% -1.6% 15.5% -11.8% -11.4% 47.0% -2.6%
Total Assets 2,422.80
3,000.36
3,704.47
4,098.36
4,530.57
5,561.98
5,629.96
6,469.31
6,708.64
growth rate 23.8% 23.5% 10.6% 5.1% 10.8% 1.2% 14.9% 3.7%
Cash 214.50
243.15
317.12
202.38
635.20
402.12
170.86
370.92
374.13
growth rate 13.4% 30.4% -36.2% 77.2% -20.4% -57.5% 117.1% 0.9%
Inventory 11.00
23.30
23.68
32.30
23.79
15.79
14.74
15.75
25.03
growth rate 111.8% 1.7% 36.4% -14.2% -18.5% -6.6% 6.9% 58.9%
Cur.Liabilities 305.90
438.72
580.11
640.43
634.32
777.87
845.40
789.60
962.69
growth rate 43.4% 32.2% 10.4% -0.5% 10.7% 8.7% -6.6% 21.9%
Liabilities 517.50
689.68
870.82
930.70
964.60
1,691.60
1,702.02
1,683.96
1,780.25
growth rate 33.3% 26.3% 6.9% 1.8% 32.4% 0.6% -1.1% 5.7%
LT Debt 67.90
86.82
136.56
111.72
62.87
512.73
513.31
513.65
438.80
growth rate 27.9% 57.3% -18.2% -25.0% 185.6% 0.1% 0.1% -14.6%
Equity 1,905.30
2,310.68
2,833.65
3,167.66
3,565.97
3,870.38
3,927.95
4,785.35
4,928.39
growth rate 21.3% 22.6% 11.8% 6.1% 4.2% 1.5% 21.8% 3.0%
Common Shares 342.00
348.00
351.00
352.00
350.00
3.50
3.54
3.59
3.62
growth rate 1.8% 0.9% 0.3% -0.6% -90.0% 0.5% 1.6% 0.8%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Jan '15 Oct '15 Jan '16 Oct '16 Dec '17 Dec '18
Capital Expenditures 0.00
104.80
183.43
352.88
276.58
362.13
459.43
362.08
446.93
growth rate 75.0% 92.4% -11.5% 14.4% 26.9% -21.2% 23.4%
Cash Dividends 0.00 0.00
growth rate
Cash From OA 456.40
546.29
708.31
695.87
847.03
1,039.93
1,245.64
1,307.68
1,454.01
growth rate 19.7% 29.7% -1.8% 10.3% 10.8% 19.8% 5.0% 11.2%
FCF per Share 0.77
0.88
1.14
0.72
0.64
0.61
1.26
1.51
2.04
growth rate 14.3% 29.6% -36.8% -11.1% -2.4% 43.7% 19.8% 35.1%
Sale Purchase of Stock 38.90
38.15
-138.64
31.88
51.48
63.79
76.71
growth rate -1.9% -100.0% 100.0% 27.1% 23.9% 20.2%
FCF 262.00
338.00
402.00
112.00
379.00
570.44
299.00
677.80
384.00
642.00
697.00
growth rate 29.0% 18.9% -72.1% 238.4% 50.5% -47.6% 126.7% -43.4% 67.2% 8.6%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Jan '15 Oct '15 Jan '16 Oct '16 Dec '17 Dec '18
Sales 1,850.20
2,203.15
2,665.44
2,910.75
3,312.82
4,352.47
4,796.47
5,142.27
5,366.33
growth rate 19.1% 21.0% 9.2% 6.7% 14.6% 10.2% 7.2% 4.4%
Op.Income 359.30
306.63
397.23
398.35
779.08
873.14
947.01
960.47
774.79
growth rate -14.7% 29.6% 0.3% 39.9% 5.9% 8.5% 1.4% -19.3%
IBT 362.20
469.69
587.71
588.05
774.17
781.38
918.43
967.13
800.85
growth rate 29.7% 25.1% 0.1% 14.7% 0.5% 17.5% 5.3% -17.2%
Net Income 237.30
306.63
397.23
398.35
525.43
539.36
636.48
866.98
630.06
growth rate 29.2% 29.6% 0.3% 14.9% 1.3% 18.0% 36.2% -27.3%
EPS 0.69
0.88
1.13
1.13
1.50
1.54
1.85
2.57
1.89
growth rate 27.5% 28.4% 0.0% 32.7% 1.3% 9.6% 38.9% -26.5%
Gross Profit 1,529.90
1,761.48
2,057.24
2,396.03
2,798.33
3,674.49
4,017.36
4,288.18
4,428.98
growth rate 15.1% 16.8% 16.5% 8.1% 14.6% 9.3% 6.7% 3.3%
R&D 203.90
286.80
301.37
338.79
392.81
539.80
551.42
605.05
683.66
growth rate 40.7% 5.1% 12.4% 7.7% 17.2% 2.2% 9.7% 13.0%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 208.29
207.16
164.13
199.94
186.12
growth rate -0.5% -20.8% 21.8% -6.9%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 1,151.86
1,210.62
1,183.49
1,159.22
1,228.99
growth rate 5.1% -2.2% -2.1% 6.0%
Acct.Payable 284.20
258.43
293.53
290.95
328.41
growth rate -9.1% 13.6% -0.9% 12.9%
Cur.Assets 2,379.39
2,386.81
2,318.80
2,423.81
2,602.47
growth rate 0.3% -2.9% 4.5% 7.4%
Total Assets 6,529.00
6,785.40
6,708.64
6,998.51
7,276.31
growth rate 3.9% -1.1% 4.3% 4.0%
Cash 510.97
498.61
374.13
503.16
702.92
growth rate -2.4% -25.0% 34.5% 39.7%
Inventory 15.35
24.74
25.03
24.10
23.16
growth rate 61.3% 1.2% -3.7% -3.9%
Cur.Liabilities 835.69
907.03
962.69
940.62
1,031.37
growth rate 8.5% 6.1% -2.3% 9.7%
Liabilities 1,650.15
1,719.67
1,780.25
1,869.36
2,559.04
growth rate 4.2% 3.5% 5.0% 36.9%
LT Debt 438.76
438.78
438.80
438.82
1,038.53
growth rate 0.0% 0.0% 0.0% 136.7%
Equity 4,878.85
5,065.73
4,928.39
5,129.15
4,717.27
growth rate 3.8% -2.7% 4.1% -8.0%
Common Shares 3.61
3.62
3.62
3.63
3.65
growth rate 0.4% 0.1% 0.2% 0.5%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 109.28
116.96
140.98
119.26
158.61
growth rate 7.0% 20.5% -15.4% 33.0%
Cash Dividends
growth rate
Cash From OA 299.70
338.45
406.89
317.27
206.81
growth rate 12.9% 20.2% -22.0% -34.8%
Sale Purchase of Stock 11.31
growth rate
FCF 190.42
221.50
265.91
198.01
48.20
growth rate 16.3% 20.1% -25.5% -75.7%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 1,367.73
1,340.07
1,365.66
1,389.88
1,431.06
growth rate -2.0% 1.9% 1.8% 3.0%
Op.Income 208.29
207.16
164.13
199.94
186.12
growth rate -0.5% -20.8% 21.8% -6.9%
IBT 214.88
214.10
171.79
206.38
154.12
growth rate -0.4% -19.8% 20.1% -25.3%
Net Income 169.36
169.38
131.32
166.22
126.97
growth rate 0.0% -22.5% 26.6% -23.6%
EPS
growth rate
Gross Profit 1,128.94
1,109.74
1,128.71
1,136.67
1,162.39
growth rate -1.7% 1.7% 0.7% 2.3%
R&D 168.28
172.30
181.47
180.36
181.05
growth rate 2.4% 5.3% -0.6% 0.4%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (67.04)

YOY Growth Grade:

C (64.94)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 35.44 37.41 21.45
EPS / Growth 15.2% 1.92 17.8%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 10.6%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 10.6% 14.6% 14.6%
Future PE 21.28 28.66 28.66
Future EPS 5.27 7.46 7.46
Value Price
MOS %
27.75
-61.4%
52.89
-26.3%
52.89
-26.3%
MOS Price 13.87 26.45 26.45
IRT 15.08 12.87 12.87

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.